Incidence of neutropenia in patients with ticlopidine/Ginkgo biloba extract combination drug for vascular events: A post-marketing cohort study

BACKGROUND AND PURPOSE: The ticlopidine/Ginkgo biloba ext. combination drug (Yuclid) is used as an antiplatelet agent for prevention of vascular events since its approval in 2008. The purpose of this study is to explore the safety of ticlopidine/Ginkgo biloba combination, mainly regarding the incide...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Han-Gil, Yoon, Jae Sun, Lee, Juneyoung, Bae, Hee-Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550423/
https://www.ncbi.nlm.nih.gov/pubmed/31166961
http://dx.doi.org/10.1371/journal.pone.0217723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550423/
https://www.ncbi.nlm.nih.gov/pubmed/31166961
http://dx.doi.org/10.1371/journal.pone.0217723

Ejemplares similares